Related Experiment Video
Updated: Jul 17, 2026

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
Development of specific growth charts for children with Fanconi anemia
Crystal Barbus1, Arpana Rayannavar1, Bradley S Miller1
1Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School and M Health Fairview Masonic Children's Hospital, Minneapolis, Minnesota, USA.
Insights
Fanconi anemia (FA) patients exhibit unique growth patterns. Developing FA-specific growth charts is crucial for accurate monitoring and management of growth in these individuals.
Area of Science:
- Pediatrics
- Genetics
- Endocrinology
Background:
- Patients with Fanconi anemia (FA) often show growth deviations when assessed using general population growth charts.
- Accurate growth assessment is vital for managing FA patients and requires tailored reference standards.
Purpose of the Study:
- To develop Fanconi anemia-specific growth charts for height, weight, and BMI.
- To compare FA growth trajectories with existing WHO and CDC growth standards.
Main Methods:
- Height and weight data were collected from 0-20-year-old FA patients at the University of Minnesota.
- Growth curves were generated using the Lambda-Mu-Sigma method and fitted to reference percentiles.
- FA-specific percentiles were compared against WHO (0-2 years) and CDC (2-20 years) standards.
Main Results:
- FA males' 50th height and weight percentiles align with the 3rd percentile of reference charts.
- FA females' 50th height percentile aligns with the 3rd reference percentile; weight shows failure then stabilization.
- FA BMI-for-age percentiles mirror weight patterns but differ in adiposity rebound timing and female variability.
Conclusions:
- Growth in Fanconi anemia patients follows a distinct trajectory compared to normative data.
- FA-specific growth charts are essential for precise growth expectation setting, evaluation, and treatment guidance.
Abstract:
Patients with Fanconi anemia (FA) are often perceived to have poor growth when general population growth curves are utilized. We hypothesize that FA patients have unique growth and aimed to create FA-specific growth charts. Height and weight data from ages 0 to 20 years were extracted from medical records of patients treated at the Fanconi Anemia Comprehensive Care Clinic at the University of Minnesota. Height, weight, and BMI growth curves were generated and fitted to reference percentiles using the Lambda-Mu-Sigma method. FA-specific percentiles were compared to WHO standards for ages 0-2 and CDC references for ages 2-20. In FA males, the 50th height- and weight-for-age percentiles overlap with the 3rd reference percentile. In FA females, only the 50th height-for-age percentile overlaps with the 3rd reference percentile. For weight, FA females show progressive growth failure between 6 and 24 months followed by stabilization around the 50th percentile. The FA BMI-for-age percentiles show similar patterns to the weight-for-age percentiles but have different timing of onset of adiposity rebound and broader variability in females. Growth in FA patients follows a different trajectory than available normative curves. FA-specific growth charts may be useful to better guide accurate growth expectations, evaluations, and treatment.

